 |
인쇄하기
취소
|
KFDA to revise Drug Review Standards.
KFDA announced a newly revised "Drug Review Standards" covering the required data in details according to Article 31 Paragraph 1 of the working rule of the Pharmaceutical Affairs Act.
The detailed attachment of such data include 1) safety and efficacy data resulted from the use and special survey, 2) domestic and overseas safety data for the adverse reactions, 3) the safety reports from dome...
The detailed attachment of such data include 1) safety and efficacy data resulted from the use and special survey, 2) domestic and overseas safety data for the adverse reactions, 3) the safety reports from dome...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.